Recent developments in in-vitro assessment of advanced glycation end products

dc.authorscopusid57208514057
dc.authorscopusid36665698000
dc.authorscopusid57216201563
dc.authorscopusid57213160335
dc.contributor.authorSerin, Yeliz
dc.contributor.authorAkbulut, Gamze
dc.contributor.authorUgur, Halime
dc.contributor.authorYaman, Mustafa
dc.contributor.authorYaman, Mustafa
dc.date.accessioned2022-03-04T19:12:12Z
dc.date.available2022-03-04T19:12:12Z
dc.date.issued2021
dc.departmentİZÜ
dc.description.abstractRecent changes in dietary habits have led to increased intake of dietary advanced glycation end products (AGEs). As AGEs play a notable role in many diseases, it is important to understand the role of AGEs in the whole metabolic processes. The aim of this review is to explain the biological formation, digestion, and absorption of AGEs, and to examine the in vitro methodologies used for determination of bioaccessibility of AGEs. As human trials are often costly, resource-intensive, and ethically controversial, the standardized static in vitro digestion method is recommended to obtain comparable results of AGEs digestibility and to understand how to decrease or prevent AGEs. More in vitro research on this topic needs to be conducted to give better nutritional recommendations.
dc.identifier.doi10.1016/j.cofs.2021.03.011
dc.identifier.endpage143
dc.identifier.issn2214-7993
dc.identifier.issn2214-8000
dc.identifier.scopus2-s2.0-85104109387
dc.identifier.scopusqualityQ1
dc.identifier.startpage136
dc.identifier.urihttps://doi.org/10.1016/j.cofs.2021.03.011
dc.identifier.urihttps://hdl.handle.net/20.500.12436/3118
dc.identifier.volume40
dc.identifier.wosWOS:000738717400021
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier Sci Ltd
dc.relation.ispartofCurrent Opinion in Food Science
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBETA-LACTOGLOBULIN
dc.subjectMAILLARD REACTION
dc.subjectFOOD
dc.subjectDIGESTION
dc.subjectMETHYLGLYOXAL
dc.subjectENDPRODUCTS
dc.subjectGLYCOTOXINS
dc.subjectPROTEINS
dc.subjectGLYOXAL
dc.subjectCASEIN
dc.titleRecent developments in in-vitro assessment of advanced glycation end products
dc.typeReview Article
dspace.entity.typePublication
relation.isAuthorOfPublication11d96fd1-2720-451c-867d-b4d03a4b11d6
relation.isAuthorOfPublication.latestForDiscovery11d96fd1-2720-451c-867d-b4d03a4b11d6

Dosyalar